TCRX 8-K 2026-09-02

TScan Therapeutics, Inc. (TCRX) 8-K dated 2026-09-02 — accession 0001193125-26-379343. This URL is the filing, not the TCRX hub.

TScan Therapeutics, Inc. (TCRX) is a biotechnology company listed on NASDAQ.

TScan Therapeutics, Inc. filed a 8-K on 2026-09-02. Accession 0001193125-26-379343.

Cached items: 2.05, 3.01, 5.02, 7.01, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported TCRX revenue for 2026-06-30 was $2.0M. Net income was -$59.0M. TCRX currently screens at market cap $62.1M.

Not investment advice. The TCRX SEC hub lists recent forms. The stock page is the research view.